Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Corcept Therapeutics Inc
LSE:0I3Q
Corcept Therapeutics Inc
LSE:0I3Q
Price:
73.96
USD
-0.7%
Market Cap:
$7.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
0I3Q Price Forecast
Based on 7 analysts
Based on 7 analysts
+125% Upside
from
$73.96
today
Corcept Therapeutics Inc (0I3Q)’s 12-month stock price forecast through November 2027 has a consensus target of $166.39, implying 125% upside. The forecast is based on price targets from 7 Wall Street analysts.
0I3Q Analyst Rating
No ratings yet
No ratings yet
Corcept Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0I3Q's stock price target?
Price Target
166.39
USD
166.39
USD
According to Wall Street analysts, the average 1-year price target for 0I3Q is 166.39 USD with a low forecast of 50.69 USD and a high forecast of 182.35 USD.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
158%
158%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 158%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.
